1.1 Research Objective

1.2 Product Overview

1.3 Market Segmentation

2.1 Qualitative Research
2.1.1 Primary & Secondary Sources

2.2 Quantitative Research
2.2.1 Primary & Secondary Sources

2.3 Breakdown of Primary Research Respondents, By Region

2.4 Assumption for the Study

2.5 Market Size Estimation

2.6. Data Triangulation

Executive Summary: Asia Pacific Continuous Glucose Monitoring (CGM) Market  

4.1. Industry Value Chain Analysis
4.1.1. Developer
4.1.2. Technology Integrator
4.1.3. Service Provider
4.1.4. End User

4.2. Industry Outlook
4.2.1. Prevalence of diabetes in Asia Pacific 
4.2.2. Sales of Continuous Glucose Monitoring Devices in Asia Pacific 

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook
4.7.2. Price Trend Analysis, By Product

4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2022
4.8.3. Competitor Mapping  

5.1. Key Insights

5.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
5.2.1. Sensors 
5.2.2. Transmitters & Receivers 
5.2.3. Integrated Insulin Pumps
5.2.4. Others

6.1. Key Insights

6.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
6.2.1. Child Population (<14 years)
6.2.2. Adult Population (>14 years)

7.1. Key Insights

7.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
7.2.1. Diagnostics/Clinics
7.2.2. ICUs
7.2.3. Home Healthcare

8.1. Key Insights

8.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Australia & New Zealand
8.2.6. Indonesia
8.2.7. ASEAN
8.2.7.1. Malaysia
8.2.7.2. Thailand
8.2.7.3. Philippines
8.2.7.4. Vietnam
8.2.7.5. Singapore
8.2.8. Rest of Asia Pacific

9.1. Key Insights

9.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
9.2.1. By Component
9.2.2. By Demographics
9.2.3. By End User

10.1. Key Insights

10.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
10.2.1. By Component
10.2.2. By Demographics
10.2.3. By End User

11.1. Key Insights

11.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
11.2.1. By Component
11.2.2. By Demographics
11.2.3. By End User

12.1. Key Insights

12.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
12.2.1. By Component
12.2.2. By Demographics
12.2.3. By End User

13.1. Key Insights

13.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
13.2.1. By Component
13.2.2. By Demographics
13.2.3. By End User

14.1. Key Insights

14.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
14.2.1. By Component
14.2.2. By Demographics
14.2.3. By End User
14.2.4. By Country

15.1. Key Insights

15.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
15.2.1. By Component
15.2.2. By Demographics
15.2.3. By End User

16.1. Key Insights

16.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
16.2.1. By Component
16.2.2. By Demographics
16.2.3. By End User

17.1. Abbott Laboratories
17.2. DexCom, Inc.
17.3. A. Menarini Diagnostics
17.4. Echo Therapeutics, Inc.
17.5. GlySens Incorporated
17.6. Johnson & Johnson
17.7. Medtronic plc
17.8. Senseonics Holdings, Inc.
17.9. F. Hoffmann-La Roche Ltd.
17.10. Other Prominent Players